Napo Pharmaceuticals Articles
ICDR rules in favor of Glenmark over Crofelemer
23 August 2012
Salix files Crofelemer NDA as spat with Napo moves to Glenmark
15 December 2011
Showing 1-4 of 4 articles
- 1
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Pfizer to split-off remaining 80% interest in Zoetis
